Loading
Latest filing published 22 Nov 2019 for BIOSPECIFICS TECHNOLOGIES CORP.
No signal scores available.
Patrick M. Caldwell appears in our data through filings on Biospecifics Technologies Corp shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 3 June 2019 and the latest from 1 October 2019.
Every open-market trade on record is a sale: 1 sale worth €314k. The rest of the record consists of 2 share grants.
The record was last updated on 22 November 2019 with a share grant in Biospecifics Technologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations